Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Issue 23 (21st October 2022)

• Record Type: Journal Article
• Authors: Wang, Wenxian; Wang, Qian; Xu, Chunwei; Li, Ziming; Song, Zhengbo; Zhang, Yongchang; Cai, Xiuyu; Zhang, Shirong; Lian, Bin; Li, Wen; Liu, Anwen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Pu, Xingxiang; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Xie, Congying; Zhang, Junping; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Wang, Liping; Zhu, Youcai; Hu, Xiao; Xie, Yanru; Lin, Xinqing; Cai, Jing; Lan, Fen; Feng, Huijing; Wang, Lin; Yao, Wang; Shi, Xuefei; Huang, Jianhui; Chen, Huafei; Zhang, Yinbin; Sun, Pingli; Wan, Bing; Pang, Fei; Xu, Zanmei; Wang, Kai; Xia, Yuanli; Ye, Mingxiang; Wang, Dong; Wei, Qing; Feng, Shuitu; Zhou, Jianya; Zhang, Jiexia; Lv, Donglai; Gao, Wenbin; Kang, Jing; Yu, Genhua; Liang, Xianbin; Yu, Chengtao; Shi, Lin; Yang, Nong; Wu, Lin; Hong, Zhuan; Hong, Wei; Fang, Meiyu; Zhang, Yiping; Lu, Yuanzhi; Wang, Guansong; Ma, Shenglin; Si, Lu; Fang, Wenfeng; Song, Yong;
• Is Part Of: Thoracic cancer. Volume 13:Issue 23(2022)
• Page Start: 3420
• Page End: 3430
• Publication Date: 2022-10-21
• Subjects: checkpoint inhibitor pneumonitis -- Chinese experts consensus -- immune checkpoint inhibitor‐related adverse effects; Chest -- Cancer -- Periodicals; Chest -- Cancer -- Treatment -- Periodicals; Chest -- Surgery -- Periodicals; 616.99494005
• DOI: 10.1111/1759-7714.14693
• Languages: English
• ISSNs: 1759-7706

Abstract

Abstract: Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to clinicians. To guide the diagnosis and treatment of CIP, we conducted in‐depth discussions based on the latest evidence, forming a consensus among Chinese experts on the multidisciplinary management of CIP. Abstract : Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.